JP Morgan Chase’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.6M Sell
785,505
-142,921
-15% -$2.86M ﹤0.01% 2295
2025
Q4
$15.1M Sell
928,426
-145,439
-14% -$2.2M ﹤0.01% 2308
2025
Q3
$12.6M Buy
1,073,865
+951,495
+778% +$12.4M ﹤0.01% 2519
2025
Q2
$1.42M Sell
122,370
-80,520
-40% -$734K ﹤0.01% 4157
2025
Q1
$1.77M Sell
202,890
-94,012
-32% -$1.19M ﹤0.01% 3964
2024
Q4
$4.26M Sell
296,902
-58,586
-16% -$925K ﹤0.01% 3488
2024
Q3
$8.03M Buy
355,488
+277,355
+355% +$5.73M ﹤0.01% 2805
2024
Q2
$1.52M Sell
78,133
-1,301
-2% -$34.1K ﹤0.01% 3988
2024
Q1
$2.98M Sell
79,434
-1,395,852
-95% -$61.3M ﹤0.01% 3517
2023
Q4
$82.6M Buy
1,475,286
+243,124
+20% +$10.6M 0.01% 983
2023
Q3
$50.8M Sell
1,232,162
-111,170
-8% -$5.78M 0.01% 1113
2023
Q2
$75M Buy
1,343,332
+70,597
+6% +$3.82M 0.01% 953
2023
Q1
$71M Buy
1,272,735
+10,835
+0.9% +$506K 0.01% 938
2022
Q4
$46M Buy
1,261,900
+55,496
+5% +$1.81M 0.01% 1160
2022
Q3
$34.4M Buy
1,206,404
+196,482
+19% +$7.49M 0.01% 1243
2022
Q2
$45.7M Buy
1,009,922
+926,161
+1,106% +$48.1M 0.01% 1088
2022
Q1
$6.37M Sell
83,761
-63,593
-43% -$5.56M ﹤0.01% 2787
2021
Q4
$21.9M Sell
147,354
-80,199
-35% -$12.3M ﹤0.01% 1746
2021
Q3
$33.1M Buy
227,553
+181,175
+391% +$31.1M ﹤0.01% 1405
2021
Q2
$9.08M Sell
46,378
-55,867
-55% -$10.1M ﹤0.01% 2505
2021
Q1
$18.5M Sell
102,245
-46,057
-31% -$7.95M ﹤0.01% 1823
2020
Q4
$21M Sell
148,302
-35,942
-20% -$5.22M ﹤0.01% 1580
2020
Q3
$23M Sell
184,244
-91,456
-33% -$9.6M ﹤0.01% 1413
2020
Q2
$24.6M Buy
275,700
+31,443
+13% +$2.45M 0.01% 1241
2020
Q1
$15.2M Sell
244,257
-25,049
-9% -$1.95M ﹤0.01% 1439
2019
Q4
$20.5M Buy
269,306
+54,155
+25% +$3.26M ﹤0.01% 1572
2019
Q3
$10.8M Buy
+215,151
New +$11.9M ﹤0.01% 2081

Other funds holding TXG